Old Web
English
Sign In
Acemap
>
authorDetail
>
James Eubanks
James Eubanks
Medicine
CD20
Physical therapy
Diabetes mellitus
Rituximab
4
Papers
22
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
B cell depletion with ublituximab reshapes the T cell profile in multiple sclerosis patients
2019
Journal of Neuroimmunology
Amy E. Lovett-Racke
Matthew Gormley
Yue Liu
Yuhong Yang
Calsey Graham
Sibyl Wray
Michael K. Racke
Richard A. Shubin
Cary Twyman
Enrique Alvarez
Ann Bass
James Eubanks
Edward Fox
Show All
Source
Cite
Save
Citations (18)
Final MRI Results At 6 Months From A Phase 2 Multicenter Study Of Ublituximab, A Novel Glycoengineered Anti-CD20 Monoclonal Antibody (mAb), In Patients With Relapsing Forms Of Multiple Sclerosis (RMS), Demonstrates Complete Elimination Of Gd-Enhancing Lesions (P3.409)
2018
Neurology
Matilde Inglese
Maria Petracca
Sirio Cocozza
Sibyl Wray
Michael K. Racke
Richard Shubin
Cary Twyman
Wendy Su
James Eubanks
Koby Mok
Michael D. Weiss
Edward Fox
Show All
Source
Cite
Save
Citations (0)
Preliminary results of Phase 2 Multicenter Study of Ublituximab (UTX), a novel glycoengineered anti-CD20 monoclonal antibody (mAb), in patients with relapsing forms of Multiple Sclerosis (RMS) demonstrates rapid and robust B cell depletion (P6.348)
2017
Neurology
Amy E. Lovett-Racke
Yue Liu
Michael K. Racke
Richard Shubin
Sibyl Wray
Wendy Su
James Eubanks
Edward Fox
Show All
Source
Cite
Save
Citations (4)
Choice of Initial Pharmacotherapy Treatment in Older Adults with Parkinson’s Disease: Associations with Health Outcomes (P7.341)
2015
Neurology
ElizaBeth Grubb
Robert G. Feldman
Jan Faiola
James Eubanks
Michael Treglia
Maureen J. Lage
Show All
Source
Cite
Save
Citations (0)
1